Detailed Insights

Debt & Fixed Income

Bayer cross in Shanghai in front of foggy sky

We continually strive to be a reliable and valued partner in the financial markets. Debt capital investors are key to our financing strategy and success. For your convenience, we’ve provided below a variety of resources including our debt investor presentation as a summary overview, our key ratings and current bonds outstanding.

 

Our Debt Investor presentation streamlines our key credit-related data into one accessible document.

 

If you have any further questions related to debt capital, please do not hesitate to contact us.

 

Bonds Outstanding

Bayer refinances the business mainly through U.S. Dollar and Euro debt capital markets. Below you find a list of all currently outstanding bonds issued by Bayer Group entities. Please note that we cannot provide prospectuses for any of these securities for legal reasons.

 

Rating

Ratings from internationally recognized agencies allow lenders to assess the risk inherent in financial instruments as companies seek to raise funds in the capital markets by issuing bonds, commercial paper, or other debt instruments. These agencies have confirmed the following ratings, which allow us to access capital markets to issue bonds. With a proven track record of disciplined deleveraging, Bayer remains committed to meeting the “A” target category rating through the long-term.

Rating agencyLong-term ratingShort-term ratingOutlook
S&P Global RatingsBBBA-2stable
Moody'sBaa2P-2negative
Fitch RatingsBBBF2stable

 

The analysts responsible for Bayer’s credit rating are:

S&P Global Ratings

Guillaume Benoit

Tel +33-1-4420-6686

E-Mail: guillaume.benoit@spglobal.com

 

Moody's

Moritz Melsbach

Tel +49-69-7073-0784

E-Mail: moritz.melsbach@moodys.com

 

Fitch Ratings

Frank Orthbandt

Tel +44-20-3530-1037

E-Mail: frank.orthbandt@fitchratings.com

 

Alejandro Marín Martínez

Tel +34-91702-5770

E-Mail: alejandro.marinmartinez@fitchratings.com

 

Debt Investor News

Below you will find all bond-related investor news.

Investor News November 17, 2023 

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer places new bonds with a volume of 5.75 billion U.S. dollars

MORE


Investor News September 20, 2023 

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues 1.75 billion euro hybrid bond

MORE


Investor News March 22, 2022 

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer refinances 1.3 billion euro hybrid bond

MORE


Investor News January 07, 2021 

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues new senior bonds with a volume of 4 billion euros

Issuance of four tranches with maturities between 4 and 15 years was substantially oversubscribed MORE


Investor News July 01, 2020

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues new senior bonds with a volume of 6 billion euros

Issuance of four tranches with maturities between 4 and 15 years was substantially oversubscribed MORE


Investor News November 07, 2019

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer refinances 1.75 billion euro hybrid bond

New issue of two tranches with a non-call period of 5.5 and 8 years combined with a tender offer for Bayer's existing hybrid bond MORE


Investor News December 18, 2018

Bayer extends credit line and increases volume to 4.5 billion euros

MORE